On Sunday September 27 the newspaper La Vanguardia published an article signed by Jaume Reventós, director of the Bellvitge Biomedical Research Institute(IDIBELL) about to combine efforts in biomedicine. In the article the director of IDIBELL advocates a “strategic rethinking of biomedical research.” He remembers that the enemy to defeat is disease either as cancer, diabetes […]
On September 18 was held for the first Cafè de la innovació” at the University Hospital of Bellvitge. It is an initiative of the Innovation Unit at IDIBELL to share innovative experiences in the field of healthcare in a relaxed manner for thirty minutes, sipping a cup of coffee. The first talk was given by
Cafè de la Innovació’ launched Read More »
The project led by Marta Barrachina from the the Institute of Neuropathology at the University Hospital of Bellvitge and IDIBELL, has been selected to enter the CaixaImpulse program, a unique initiative in Spain born with the aim of promoting the transformation of scientific knowledge in companies field of life sciences and health. This project has
CaixaImpulse funds a project for early detection of Alzheimer’s disease Read More »
The group of Laura Valle at the Hereditary Cancer Program of the Catalan Institute of Oncology, IDIBELL, aims at identifying new genes for hereditary colon cancer. Through the application of techniques based on massively parallel sequencing to study of the coding parts of the genome, the researchers have identified causal mutations for hereditary colorectal cancer
FAN1, a novel gene for hereditary colon cancer Read More »
To date, patients with brain implants could not undergo neuroimaging scans for security reasons FIS research project of the Institute of Health Carlos III Reference in Spain
